Your Global
Market Access

NHTA is a boutique Market Access consultancy specialized in Health Economics

Optimizing value throughout the Market Access process, from strategy to implementation.

It starts with your needs.

With us there is no ‘one-size-fits-all’. Your specific needs and unique context are our starting point to ensure we can deliver bespoke solutions that bring the value you seek. We combine our extensive experience within evidence generation, health economics, Market Access, and communication to support your Market Access objectives.

Please take a closer look at our services.

Fit for the future 

The NHTA team consists of highly skilled and passionate people, who always strive to find optimal solutions. Market Access is heavily impacted by external changes, and these days, value based healthcare move quickly. To keep up, it is important to stay on top of future trends.

We have selected four topics in HTA for you to investigate.

A value driven consultancy

At NHTA we choose pride over profit. We focus on quality and creating value with a “No BS” approach to consulting. We have a strong track record and our international team have combined developed 100+ health economic models and research projects.

Would you like to more know more about us?

Latest news

Do you want to gain insight on market trends? Make sure to read the latest news from NHTA.

Access for Orphan drugs

In Danish hospitals it is mandatory to use the mini-HTA (mini-MTV in danish) framework when introducing new innovative treatments, especially orphan drugs, and when the individual departments apply for funding…

Welcome to Jannick and Chiara

We are very pleased to welcome both Chiara Marocco and Jannick Beck to our team. Jannick Beck primarily supports with market access activities in the Nordics, including the development of our health economic models, HTA submissions,…

Danish EQ-5D-5L value set

The Danish EQ-5D-5L value set have been published by Elgaard Jensen et al. [1].   As of 2021, the Danish Medicines Council (DMC) have implemented the use of QALYs as the preferred outcome measure of…